ANALYSISApril 13, 2026
Should GMO foods require explicit labels?
The United States has mandatory bioengineered food labeling under the National Bioengineered Food Disclosure Law, which became fully mandatory on June 23, 2025, but uses the term 'bioengineered' rather than 'GMO' and permits QR codes in lieu of on-package text. A landmark Ninth Circuit ruling in late 2025 ordered the USDA to rewrite key parts of the rule, finding that the agency unlawfully exempted highly refined and processed foods from labeling requirements on the basis that genetically engineered material was 'not detectable.' Up to 80% of products containing GMOs have avoided mandatory labeling due to this exemption, and the court also signaled that QR-code-only disclosure is insufficient.
If a food is proven safe by every major scientific body, does slapping a GMO label on it inform consumers — or just scare them? And if it scares them, does the government owe the food industry an explanation for why fear counts as disclosure?
Not familiar with this story? Get context →
80% exemption as disclosure failure
C
For five years after mandatory disclosure supposedly took effect, up to 80% of GMO-containing products carried no label — because USDA decided that refining a GMO crop into an ingredient like high-fructose corn syrup made it no longer 'bioengineered' enough to disclose. That is not a regulatory gap; it is a regulatory design choice, and the Ninth Circuit just ruled it unlawful. A disclosure regime that exempts most products is not a disclosure regime.
L
We agree on the number, so let's agree on what it means: the 2016 federal law was written to look mandatory while operating as optional. The real question is who engineered that outcome — and the answer is the industry lobby that spent heavily to preempt Vermont's Act 120, which required on-package text and covered refined products. The 80% figure is not a drafting accident; it is the point.
C
If the 80% exemption was industry capture, then the Ninth Circuit ruling is exactly the corrective mechanism conservatives should want — courts enforcing statutory limits on agency discretion. The problem isn't that labeling was required; the problem is that USDA used administrative interpretation to hollow out what Congress directed.
L
Agreed, which is why the fix has to be legislative, not just judicial — because the next USDA can hollow it out again unless the statutory language closes the refined-foods loophole explicitly.
Safety consensus versus transparency right
C
The scientific consensus on GMO safety is real and conservatives should not pretend otherwise — a Nature Biotechnology review of 20 years of studies found transgenic food as safe as conventionally produced food. But that is the wrong frame for this debate. We label caloric content not because calories are dangerous, but because consumers have a right to know what they are buying. Labeling is a transparency mechanism, not a danger signal.
L
The calorie comparison actually cuts the other way: we label calories because people make consequential daily decisions using that information. If there's no health difference between GMO and non-GMO corn syrup, what consequential decision does the label enable? I'm not saying the answer is nothing — consumer preference is real — but the transparency argument is stronger when we're honest that it's about preference, not risk.
C
We label kosher certification, country of origin, and organic status — none of which are health signals — precisely because consumer preference is a legitimate market input that producers are obligated to represent honestly. 'It's just preference' is not a reason to suppress information; it's the definition of why information matters.
L
Granted, and that's why I support labeling — but the design has to reflect what the label actually is: a preference disclosure, not a warning. 'Bioengineered' in small text on the back panel isn't that label either.
QR-code access as equity problem
C
The QR-code-only disclosure is regulatory capture dressed as modernization. A consumer without a smartphone standing in a grocery aisle is not experiencing 'flexible disclosure' — they are experiencing no disclosure. Vermont's Act 120 required on-package text; the industry-funded campaign that produced the 2016 federal law replaced that with a weaker mechanism that looks like compliance while functioning as an obstacle.
L
The equity dimension here is sharper than 'no smartphone': the 25% of Americans without reliable mobile data access skew elderly, low-income, and rural — the exact populations least able to absorb information asymmetries in markets dominated by large food conglomerates. The Ninth Circuit flagging QR-code-only disclosure as constitutionally insufficient isn't a technicality; it's a recognition that a right requiring a data plan isn't a right.
C
The constitutional point matters practically: if QR-code-only disclosure can't survive judicial review, then every manufacturer who chose that option is now exposed, and the industry got five years of non-disclosure for nothing. That is the predictable cost of letting regulatory capture substitute for genuine compliance.
L
Which returns us to Vermont's model — on-package text, no workarounds. It worked, it was enforceable, and Congress killed it at the industry's request. The court just confirmed what Act 120's supporters said in 2016.
Label language versus consumer comprehension
C
USDA chose 'bioengineered' over 'GMO' or 'genetically modified' — terms consumers actually recognize — and defended that choice administratively. A label that conveys nothing to the person reading it is not a disclosure; it is a formality dressed as one. Accurate labeling requires language that the audience can actually decode, and that is an argument for plain language, not for bureaucratic terminology selected partly because it is unfamiliar.
L
Consumer comprehension is an empirical question, and the evidence on 'bioengineered' is not reassuring — surveys show significantly lower recognition than 'GMO' or 'genetically modified.' But I'd go further: USDA's terminology choice looks like the refined-foods exemption's cousin. Both decisions reduced the practical reach of disclosure while maintaining formal compliance. One exploited a processing threshold; the other exploited a vocabulary gap.
C
If both the exemption and the terminology were chosen to minimize effective disclosure, that is a coherent regulatory strategy — and naming it as such matters, because it means reform has to address both simultaneously or the next administration simply chooses a different unfamiliar term.
L
Exactly — which is why 'GMO' or 'genetically modified' should be statutory language, not left to agency discretion. Lock it in the text so it cannot be administratively redefined.
Export stigma and labeling design tradeoff
C
The EU experience is the uncomfortable counterpoint conservatives need to take seriously: a strict labeling regime corresponded with near-total consumer rejection of GMO products across European markets. There is no guarantee the U.S. behaves differently, and American agricultural competitiveness in export markets already faces the EU stigma. This is a real cost — not a reason to maintain the 80% exemption, but an argument for label design that is clear, accurate, and non-alarmist.
L
The EU comparison doesn't travel cleanly. European GMO labeling arrived alongside sustained political panic and almost no public education — the U.S. already has two decades of public familiarity with bioengineered food that Europe lacked at its critical moment. There's no empirical evidence that a plainly worded disclosure on a cereal box triggers the same market collapse as a nationally televised health scare.
C
Two decades of familiarity without labels is exactly the condition that labeling changes — we don't know how consumers respond to explicit on-package disclosure because they haven't seen it at scale. The EU is the closest natural experiment we have, and dismissing it because the political context differed is a bet, not a finding.
L
It's a bet, yes — but the alternative bet is that keeping consumers uninformed is a stable long-term strategy, and that loses badly the moment a genuine food safety scandal, GMO-related or not, hits. Transparency now, with good label design, is lower risk than a disclosure forced under crisis conditions.
Conservative's hardest question
Mandatory GMO labeling may function in practice as an implicit warning regardless of legislative intent, given documented consumer risk associations with the term — potentially stigmatizing a technology the scientific community considers safe and undermining American agricultural competitiveness in export markets. This is not a hypothetical: the EU's strict labeling regime has corresponded with near-total consumer rejection of GMO products in those markets, and there is no guarantee the U.S. would behave differently.
Liberal's hardest question
The scientific consensus on GMO safety is genuine and robust — a Nature Biotechnology review of 20 years of studies found bioengineered food as safe as conventionally produced food — which means the strongest version of the opposition's argument is that this labeling regime exists to validate public fear rather than inform genuine risk, and that is not an easy charge to dismiss entirely.
Both sides agree: Both sides accept the scientific consensus that bioengineered food is as safe as conventionally produced food, and neither bases their labeling argument primarily on health risk.
The real conflict: The sides disagree on a question of values: conservatives frame labeling as a market-integrity and property-rights issue rooted in consumer autonomy, while liberals frame it as an equity and access issue rooted in structural disadvantage — producing the same policy conclusion from incompatible premises.
What nobody has answered: If consumers, once given clear on-package labels, respond by rejecting bioengineered foods at scale — as happened in the EU — does the right to know include the right to make choices that harm a technology the scientific community considers beneficial, and who bears responsibility for that outcome?
Sources
- Web search results: National Bioengineered Food Disclosure Law (7 U.S.C. § 1639 et seq.) summary and compliance timeline
- Web search results: Ninth Circuit Court of Appeals ruling reversing USDA exemption for highly refined bioengineered foods (late 2025)
- Web search results: Center for Food Safety et al. v. USDA litigation summary and plaintiff/intervenor identification
- Web search results: USDA Agricultural Marketing Service National Bioengineered Food Disclosure Standard regulatory history
- Web search results: EU vs. U.S. GMO labeling requirement comparison
- Web search results: Nature Biotechnology 20-year review of GMO food safety studies
- Web search results: Vermont Act 120 GMO labeling law and subsequent federal preemption
- Web search results: Consumer QR code accessibility and equity concerns in labeling policy